Could a novel strain of SARS-CoV-2 identified this month be linked to an accelerating spread in the country’s southeast?
December 7, 2020
WHO advisors are meeting today to discuss deliberately infecting young, healthy volunteers with SARS-CoV-2 to hasten vaccine development—despite the promising vaccines already on the way. Pros: Faster results than conventional vaccine field trials…
December 2, 2020
117 pages of leaked documents reveal that early in the pandemic, China offered the world a partial picture of what they knew and a more optimistic forecast than what was evidenced on the ground. Despite the virus’s novelty, there was “evidence of clear missteps” and “a…
November 18, 2020
Less disruptive and costly COVID-19 restrictions can work as well as more intrusive steps like lockdowns to slow the spread of SARS-CoV2, according to a new study ranking the effectiveness of government interventions around the world. The researchers from the Medical…
November 16, 2020
More good vaccine news broke this morning as biotech company Moderna announced
November 6, 2020
A nasal spray designed to block SARS-CoV-2 was completely protective against the virus in a small preprint study of ferrets by Columbia University and other researchers. Bonus: It’s inexpensive and doesn’t need refrigeration. If—and it’s still a…
October 28, 2020
SARS-CoV-2 antibodies wane over time, and more severe cases stir stronger immune responses, a trio of new studies concur. And while they diverge over how long antibodies last, this isn’t necessarily cause for concern.
August 3, 2020
Some people who have not been exposed to SARS-CoV-2 may still have some immunity to it—and not because they have antibodies.
July 31, 2020
Young children infected with SARS-CoV-2 carry high amounts of the viral RNA in their nasal cavities, even if they have only mild symptoms,
July 15, 2020
The Moderna candidate vaccine against SARS-CoV-2 generated an immune response and showed no serious adverse effects, the